![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2016
Zhao, Y.; Altendorf-Hofmann, A.; Janis, P.; Assmann, C.; Niess, H.; Camaj, P.; Däberitz, T.; Wang, X.; Seeliger, H.; Jauch, K.-W.; Knösel, T. und Bruns, C.
(2016):
Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
In: Oncology Research and Treatment, Bd. 39: S. 83
Sen Gupta, A.; Zhao, Y.; Qin, J.; Augsburger, D.; Zhao, L.; Camaj, P.; Wang, Y.; Nelson, P. und Bruns, C. J.
(2016):
Pilot results on effects of human hMSC in an orthotopic SCID/NOD mouse model for cholangiocarcinoma.
In: Oncology Research and Treatment, Bd. 39: S. 41
2013
Modest, D. P.; Camaj, P.; Heinemann, V.; Schwarz, B.; Jung, A.; Laubender, Rüdiger P.; Gamba, S.; Haertl, C.; Stintzing, S.; Primo, S. und Bruns, C. J.
(2013):
KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 139, Nr. 6: S. 953-961